Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer.

Published in:

International Urology & Nephrology, 2021, v. 53, n. 12, p. 2493, doi. 10.1007/s11255-021-02841-7

By:

• Möller, Katharina;
• Fraune, Christoph;
• Blessin, Niclas C.;
• Lennartz, Maximilian;
• Kluth, Martina;
• Hube-Magg, Claudia;
• Lindhorst, Linnea;
• Dahlem, Roland;
• Fisch, Margit;
• Eichenauer, Till;
• Riechardt, Silke;
• Simon, Ronald;
• Sauter, Guido;
• Büscheck, Franziska;
• Höppner, Wolfgang;
• Matthies, Cord;
• Doh, Ousman;
• Krech, Till;
• Marx, Andreas H.;
• Zecha, Henrik

Publication type:

Article